Hercules Inc and CollagenCorp said they formed an equally-owned joint venture todevelop, make and market products for the treatment of dermalwounds caused by surgery, trauma or disease.    The joint venture will focus on development of products toheal dermal wounds that are resistant to currently availabletreatment, the companies said.    They said clinical studies will focus initially on treatingwounds such as decubitus ulcers or bedsores caused by prolongedpressure and underlying diseases such as diabetes, whichcompromises the blood supply. Reuter&#3;